Table 3. Clinical trial efficacy data of licensed and available drug monotherapy.
a
Only the data of patients who had relapsed/refractory PTCL were reported.
Abbreviations: —, not available; ALCL, anaplastic large‐cell lymphoma; CR, complete remission; CRu, unconfirmed complete remission; DoR, duration of response; HDAC, histone deacetylase; MoAb, monoclonal antibodies; NR, not reached; OS, overall survival; PFS, progression‐free survival; PTCL, peripheral T‐cell lymphoma; Ref., reference; TCL, T‐cell lymphoma.